March: Zhejiang Asen obtained the production scope license for tablets (contraceptives [for registration application only]) approved by the Zhejiang Medical Products Administration.
October: Zhejiang Asen received the marketing authorization registration approval for Dydrogesterone Tablets.

June: After review by the Zhejiang Medical Products Administration, the soft capsule (hormone) production line in Zhejiang Asen's Formulation III Workshop was confirmed to comply with the "Good Manufacturing Practice (GMP) for Pharmaceutical Products".
November: Zhejiang Asen's Montmorillonite Powder obtained the "Drug Registration Certificate" from the National Medical Products Administration and was deemed to have passed the Consistency Evaluation.
December: Zhejiang Asen passed the 2024 re-recognition as a National High-Tech Enterprise.
December: Amlodipine Besylate Tablets, Atorvastatin Calcium Tablets, and Rosuvastatin Calcium Tablets obtained the "Drug Manufacturing License" from the Zhejiang Medical Products Administration.

April: Gliclazide Sustained-release Tablets officially entered production at Zhejiang Asen.
May: Approved by the Zhejiang Provincial Department of Human Resources and Social Security, Zhejiang Asen was granted the qualification as a Vocational Skill Level Recognition Enterprise, covering junior, intermediate, and senior levels of pharmaceutical preparation workers.
June: Zhejiang Asen's Ornidazole Tablets (trade name: Aoning) were approved by the National Medical Products Administration to pass the Consistency Evaluation of the Quality and Efficacy of Generic Drugs, and obtained the "Supplemental Drug Application Approval Notice".
August: Zhejiang Asen successfully passed the Intellectual Property Management System certification and obtained the "Intellectual Property Management System Certification Certificate".

July: Zhejiang Asen obtained the "Drug Manufacturing License" for Gliclazide Sustained-release Tablets from the Zhejiang Medical Products Administration.
July: Zhejiang Asen's Progesterone Soft Capsules passed the Consistency Evaluation of the Quality and Efficacy of Generic Drugs, making the company the first in China to pass the Consistency Evaluation for oral progesterone preparations.
December: Zhejiang Asen was selected as a "2022 Hangzhou Innovative Small and Medium-sized Enterprise".

March: Zhejiang Province held the kick-off meeting for the Zhejiang Food Chain Traceability Coding System. Zhejiang Asen was listed as one of the first batch of pilot enterprises for the Zhejiang Sunshine Factory and recognized as a benchmark enterprise in Qiantang District to fully implement the Zhejiang Food Chain Code.
May: Three design patents of Zhejiang Asen – Packaging Box (Calcium Supplement with Notoginseng Tablets), Packaging Box (Glycerin Enema), Packaging Box (Good Night Essential Oil) – and one utility model patent – A Tank with Built-in Temperature Monitoring Device – were granted patent authorization by the National Intellectual Property Administration.
October: Zhejiang Asen passed the review of the Hangzhou Administration for Market Regulation and was honored as a 2021 Zhejiang Provincial AA-level "Contract-honoring and Promise-keeping" Enterprise.
November: Zhejiang Asen's Yanjitang Brand Wall-Broken Ganoderma Lucidum Spore Powder obtained the filing certificate for domestic health food products.
November: Through enterprise application, district/county recommendation, expert review, and other procedures, Zhejiang Asen was recognized as a 2021 Hangzhou Patent Demonstration Enterprise.
November: Zhejiang Asen passed the water-saving assessment in Hangzhou and was awarded the title of 2021 Hangzhou Water-saving Enterprise.
December: Zhejiang Asen passed the review of the National High-Tech Enterprise Accreditation Management Leading Group Office and successfully achieved the recognition as a National High-Tech Enterprise.

June: The company passed the on-site inspection by the Zhejiang Institute for Food & Drug Control and added a new production line for tablet-based health food products.

May: Beijing Wansheng, Zhejiang Asen, and Anhui Foyou, three pharmaceutical companies, were integrated, and Beijing Foyou Pharma Co., Ltd. was officially established.
October: Eight products of Zhejiang Asen were selected as "2019 Zhejiang Provincial Excellent Industrial Products".

May: Zhejiang Yanjitang Pharmaceutical Technology Co., Ltd. was established.
October: Zhejiang Yanjitang Pharmaceutical Technology Co., Ltd. successfully passed the GSP certification.
November: Yanjitang was honored with the "Best Brand Promotion and Marketing Award for 2018" by Zhejiang Radio and Television Group.

September: Successfully passed the final acceptance review of the Industry-University-Research Cooperation Project conducted by the Science and Technology Bureau.

January: Awarded the title of "Integrity Enterprise in Zhejiang Health Products Industry".
December: Selected as a Zhejiang Innovative Demonstration Small and Medium-sized Enterprise.

July: Selected as one of the first batch of Zhejiang Provincial Sci-Tech Enterprises in Hangzhou for 2015.
September: Shortlisted as a 2015 Zhejiang Provincial Growth-oriented Small and Medium-sized Enterprise.
October: Recognized as a National High-Tech Enterprise.

December: Rated as an "Advanced Enterprise in Technological Innovation for 2013" by Hangzhou Economic and Technological Development Zone.

November: Completed the construction of the Soft Capsule Workshop and the Granule Workshop.
December: Rated as a "2012 Hangzhou Most Growth-oriented Enterprise" by the Hangzhou Economic and Information Technology Commission.

December: The company's Technology Center was officially established.

November: Re-rated as a Zhejiang Provincial High-Tech Enterprise.

May: Donated medicines valued at approximately 1.1 million RMB to the Sichuan disaster area.

December: Rated as a Zhejiang Provincial High-Tech Enterprise.

January: Obtained the New Drug Certificate for Jingangteng Soft Capsules.

August: Obtained the New Drug Certificate for Ornidazole Tablets.
November: Obtained the New Drug Certificate for Progesterone Soft Capsules.

August: Obtained the New Drug Certificate for Guipi Granules.

February: Awarded the honorary title of "Contract-honoring and Promise-keeping" Unit for 1999-2000.
December: Obtained the New Drug Certificate for Gongning Granules.

January: Rated as an annual AAA-level enterprise by the Hangzhou Credit Rating Committee.

July: Ranked second in economic benefit among chemical pharmaceutical preparation manufacturers in Zhejiang Province.
September: Approved and commenced construction of Phase II project – Extraction Workshop, Preparation Building, and Office Building.

In August 1997, the production project of Gongning Granules passed the scientific and technological achievement appraisal of the State Family Planning Commission.

August: Approved and commenced construction of Phase I project – VE Workshop and Administration Building.
October: Started construction of Phase I supporting facilities – Comprehensive Warehouse, Power Workshop, Hazardous Materials Warehouse, Tank Farm, Wastewater Treatment Facility, Garage, and Guard House.

In December 1995, Zhejiang Asen Pharmaceutical Co., Ltd. was incorporated and registered in the Hangzhou Economic and Technological Development Zone.